This website uses cookies to ensure you get the best experience on our website.
- Table of Contents

Facts about Tenascin-N.
During endochondral bone formation, inhibits proliferation and differentiation of proteoblasts mediated by canonical WNT signaling (By similarity). In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells (PubMed:19884327).
| Human | |
|---|---|
| Gene Name: | TNN |
| Uniprot: | Q9UQP3 |
| Entrez: | 63923 |

| Belongs to: |
|---|
| tenascin family |

tenascin N
Mass (kDA):
144.034 kDA

| Human | |
|---|---|
| Location: | 1q25.1 |
| Sequence: | 1; NC_000001.11 (175067833..175148075) |
Not detected in normal adult mammary tissues or brain but expressed in most breast tumors and brain tumors, such as glioblastomas, astrocytomas and oligodendrogliomas, tested (PubMed:17909022, PubMed:19884327). In brain tumors, detected around the endothelial cell layer of the clood vessels (PubMed:19884327).
Secreted, extracellular space, extracellular matrix.




PMID: 17909022 by Degen M., et al. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior.
PMID: 19884327 by Martina E., et al. Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.